¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦104Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ : 2018-09-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦104Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ : 2018-09-28
±³À°ÀÏÀÚ : 2018-09-28
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼ ÄÁº¥¼ÇŸ¿ö 5Ãþ  
±³À°ÁÖÁ¦ : Á¦104Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇÑ»êºÎÀΰúÇÐȸ
´ã´çÀÚ : »ç¹«±¹
¿¬¶ôó : 02-3445-2262  
À̸ÞÀÏ : office@ksog.org      
±³À°Á¾·ù : »êºÎÀΰú      
Âü¼®¿¹»óÀοø : 1000¸í
 Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í ÁØȸ¿ø 9¸¸¿ø/Á¤È¸¿ø 12¸¸¿ø/ºñȸ¿ø 15¸¸¿ø(»çÀüµî·Ï±âÁØ)      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 08:20~08:30 Progesterone receptor membrane component 1 in fetal membranes with preterm labor, preterm premature rupture of membrane, and chorioamnionitis  ÃÖ¼ö¶õ(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 08:30~08:40 Effects of folic acid and progesterone on preterm premature rupture of membrane treatment model  °­¹ÎÁ¤(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 08:40~08:50 Routine use or non-use of antenatal magnesium sulfate exposure for neuroprotection and risk of necrotizing enterocolitis in preterm neonates  È«ÁöÀ±(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 08:50~09:00 Individualized assessing prediction models of the impact of preterm birth on risk factors at admission: A KOrean Preterm collaboratE Network (KOPEN) registry data-based cohort study  ÀÌ°æÁÖ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 09:00~09:10 Non-invasive prediction of intra-amniotic infection/inflammation in women with preterm premature rupture of membranes: analysis of various immune-related proteins in cervicovaginal fluid  À̼¼Áø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 09:10~09:20 Therapeutic effect of conditioned media from amniotic fluid-derived mesenchymal stem cell on preterm birth by immunomodulation  ÃÖÇýÁø(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 09:20~09:30 Global gene expression analysis of cell-free RNA in amniotic fluid from women destined to develop preeclampsia  ±èÇѳª(Â÷ÀÇ°úÇдë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 09:30~09:40 A comparison analysis between cervical elasticity and cervical consistency index at mid-trimester  ¼º°æ¿í(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 09:40~09:50 The relationship between selenoprotein P and pregnancy-associated HTN  Á¤¿µ¹Ì(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 09:50~10:00 In utero exposure of ritodrine during pregnancy and risk of autism until 8 years of age: Korea National Health Insurance (KNHI) data base analysis  Ã¤Á¤¼ö(¼º±Õ°üÀÇ´ë) 
È޽Ġ09¿ù 28ÀÏ ¹éµÎȦ 10:00~10:20 Coffee Break  () 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 11:10~11:30 The current state of fetal therapy in Japan  Haruhiko Sago(National Center for Child Health and Development) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 11:30~11:50 The elderly gravidas: What are the risk?  Haywood L. Brown(Immediate Past President of ACOG) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 11:50~12:10 The management of ovarian endometrial cysts  Kaori Koga(Univ of Tokyo) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 12:10~12:30 HIPEC during interval debulking surgery for advanced ovarian cancer prolongs overall survival. How to continue?  Jacobus van der Velden(Academic Medical Center) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 12:30~12:50 ºÎÀΰúÀû Áúȯ¿¡¼­ÀÇ ¹Ì·¹³ªÀÇ Ä¡·áÈ¿°ú  ÀÌÁö¿µ(°Ç±¹ÀÇ´ë) 
½Ä»ç 09¿ù 28ÀÏ ¹éµÎȦ 12:50~13:40 Lunch  () 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 13:40~14:10 ÁÖº¯ ±¹°¡ÀÇ ºÒ°¡Ç×·Â ÀÇ·á»ç°í º¸»óÁ¦µµÀÇ ÀÌÇØ ¹× ¿ì¸®³ª¶ó Á¦µµÀÇ Æ¯¼º  ¹ÚÀξç(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 14:10~14:40 KSOG position statement on prophylactic salpingectomy in the benign condition  ±è¹Ì¼±(Â÷ÀÇ°úÇдë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éµÎȦ 14:40~15:00 ÃÖ±Ù Áõ°¡ÇÏ´Â ¹éÀÏÇØ ¿¹¹æÀ» À§ÇÑ Tdap vaccine guideline update  È«¼øö(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éÁ¦È¦ 15:00~15:10 The influence of maternal nutrition during pregnancy on offspring growth and behavior in rat  Á¶¾Æ¿µ(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éÁ¦È¦ 15:10~15:20 The prevalence and clinical features contributing alcohol drinking in current pregnancy in Korea  À̼öÁ¤(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éÁ¦È¦ 15:20~15:30 Cesarean section and risk factors: Secular tends in South Korea, 2006-2015  ¹è³ª¿µ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éÁ¦È¦ 15:30~15:40 Wireless ultrasonography guided uterine incision in cesarean section  Á¶°æÁÖ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éÁ¦È¦ 15:40~15:50 Maternal and neonatal adverse outcomes following induced labor in women with a long cervix comparing in women with a short one  Á¶¼öºó(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éÁ¦È¦ 15:50~16:00 Maternal Body Mass Index and physical activity in relation with onset of spontaneous labor in full term women expecting normal spontaneous vaginal delivery  È«±â¸²(Â÷ÀÇ°úÇдë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éÁ¦È¦ 16:00~16:10 Prader-Willi syndrome originated from Uniparental Disomy(UPD) prenatally diagnosed by DNA methylation analysis and methylation specific-multiplex ligation-dependent probe amplification(MS-MLPA)  ½É¼ÒÇö(Â÷ÀÇ°úÇдë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éÁ¦È¦ 16:10~16:20 Gestational age-specific risk of stillbirth during term pregnancy according to maternal age  ¹ÚÀ翵(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éÁ¦È¦ 16:20~16:30 Obstetrical outcomes of amniocentesis or chorionic villus sampling in dichorionic twin pregnancies  À̼öºó(Â÷ÀÇ°úÇдë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éÁ¦È¦ 16:30~16:40 Composition of vaginal microbiota in pregnant Korean women with bacterial vaginosis diagnosed by Nugent score  ÀÓö±Ç(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éÁ¦È¦ 16:40~16:50 Perinatal outcome of histologic chorioamnionitis in women with preterm premature rupture of membranes  À̼¼¿µ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éÁ¦È¦ 16:50~17:00 Comparison of subsequent pregnancy outcomes according to the presence of acute histologic chorioamnionitis in women with spontaneous preterm delivery  ±è³²°æ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éÁ¦È¦ 17:00~17:10 Predictive value for adverse pregnancy outcome of quad serum markers in antiphospholipid antibody syndrome  È«¼­¿¬(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ ¹éÁ¦È¦ 17:10~17:20 Risk factors associated with idiopathic sudden sensorineural hearing loss during pregnancy in South Korea: a nationwide population-based study  ¼ÛÇö¼÷(ÀÎÁ¦ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦104Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ : 2018-09-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÇǺΰúÇÐȸ ºÎ»ê¿ï»ê°æ³² ÁöºÎȸ : 2018-09-28
´ÙÀ½±Û ÇѸ²´ëÇб³Ãáõ¼º½Éº´¿ø Áö¿ªÀǾàÇ°¾ÈÀü¼¾ÅÍ ½ÉÆ÷Áö¾ö : 2018-09-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
63 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø Á¦7ȸ Áö¿ª»çȸº´¿ø°ú ÇÔ²²ÇÏ´Â °¨¿°°ü¸® ½ÉÆ÷Áö¿ò : 2018-08-18 0 888 2018-07-28
62 ¼­¿ï 2018 ÇÏ°è ºÐÀÚÆó¾Ï¿¬±¸È¸ Àӻ󿬱¸ ¿öÅ©¼ó : 2018-08-18 0 543 2018-07-28
61 ¼­¿ï ´ëÇÑ¿Ü°úÃÊÀ½ÆÄÇÐȸ ÃÊÀ½ÆÄ °Ë»ç ±Ç°í¾È ½ÉÆ÷Áö¾ö : 2018-08-18 0 776 2018-07-28
60 ºÎ»ê 2018³â ´ëÇѼÒÈ­±â¿¬°üÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2018-08-18 0 675 2018-07-28
59 ¼­¿ï ´ëÇÑ»êºÎÀΰúÀÇ»çȸ&Çѱ¹¹ß»ý»ý¹°ÇÐȸ Joint Symposium : 2018-08-18 0 1,080 2018-07-28
58 ¼­¿ï ´ëÇѺ´¸®ÇÐȸ 8th Ç÷¾×º´¸® ¿¬¼ö±³À° : 2018-08-18 0 711 2018-07-28
57 ¼­¿ï ´ëÇѴٹ߼º°æÈ­ÁõÇÐȸ 2018³â ¿¬·ÊÇмú´ëȸ : 2018-08-18 0 839 2018-07-28
56 ¼­¿ï ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ 2018³âµµ Á¦2Â÷ ÁöµµÀü¹®ÀÇ ±³À° : 2018-08-17 0 857 2018-07-28
55 °­¿ø ´ëÇѽÉÀåÇÐȸ Ç÷°ü¿¬±¸È¸ ÇÏ°è½ÉÆ÷Áö¾ö : 2018-08-17 0 1,286 2018-07-28
54 ¼­¿ï Á߾Ӵ뺴¿ø »êºÎÀΰú žÆÃÊÀ½ÆÄ ¿¬¼Ó°­Á : 2018-08-16 0 659 2018-07-28
53 ¼­¿ï °Ç±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ ¿¬¼ö±³À°(ÈĵÎÁúȯ) : 2018-08-16 0 728 2018-07-28
52 ¼­¿ï ´ëÇÑÀÇ»çÇùȸ [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] °Ç°­º¸Çè ¼ö°¡°áÁ¤ : 2018-08-16 0 865 2018-07-28
51 ¼­¿ï Çѱ¹¿ªÇÐȸ Biomarker ¸¦ ÀÌ¿ëÇÑ ¿¬±¸ ¼³°è¿Í ºÐ¼® : 2018-08-14 0 1,277 2018-07-28
50 ¼­¿ï Á¦240ȸ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ¿ù·Ê ÇмúÁý´ãȸ : 2018-08-14 0 423 2018-07-28
49 ¼­¿ï Çѱ¹¿ªÇÐȸ MR ±â¹Ý À¯Àüü ¿ªÇבּ¸¿Í °ø°ø°Ç°­ÀÚ·á ±â¹Ý Outcome research : 2018-08-13 0 646 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409 | 1410
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷